nalalpha-[(benzyloxy)carbonyl]-n-[(1r)-4-hydroxy-1-methyl-2-oxobutyl]-l-phenylalaninamide

NALPHA-[ (BENZYLOXY)CARBONYL ] -N-[ ( 1R ) -4-HYDROXY - 1-METHYL - 2-OXOBUTYL ] L-PHENYLALANINAMIDE is a small molecule organic compound classified as an amino acid derivative, specifically a phenylalanine and derivatives class member. It is not approved for any clinical use and has no known therapeutic indications or clinical trials reported. The compound features a benzoyl-protected phenylalanine residue linked to a hydroxy-keto butanamide moiety, suggesting potential utility in peptide synthesis or as an intermediate in medicinal chemistry research[5][6][8].

Other names

nalpha-[(benzyloxy)carbonyl]-n-[(1r)-4-hydroxy-1-methyl-2-oxobutyl]-l-phenylalaninamidebenzyl n-((1s)-1-(((2r)-5-hydroxy-3-oxopentan-2-yl)carbamoyl)-2-phenylethyl)carbamatebenzyl n-[ (1s)-1-[ [(2r)-5-hydroxy-3-oxopentan - 2-yl] carbamoyl ] - 2-phenylethyl ] carbamatenalpha-( (benzyloxy ) carbonyl ) -n-( ( 1r ) -4-hydroxy - 1-methyl - 2-oxobutyl ) - l-phenylalaninamide[6][5][7]